1
Clinical Trials associated with TB/FLU-01L Tuberculosis Vaccine(RIBSP)A Randomized, Open Clinical Trial Phase 1 Vaccine TB/FLU-01L by Intranasal and Sublingual Application for Specific Immunotherapy Pulmonary Tuberculosis
The study is a single centre, phase I, open, randomized, by intranasal and sublingual application trial that explored the safety and immunogenicity of 2 doses (Day 1 and Day 21) TB/FLU-01L tuberculosis vaccine in BCG-vaccinated healthy adult subjects aged 18-50 years.
100 Clinical Results associated with TB/FLU-01L Tuberculosis Vaccine(RIBSP)
100 Translational Medicine associated with TB/FLU-01L Tuberculosis Vaccine(RIBSP)
100 Patents (Medical) associated with TB/FLU-01L Tuberculosis Vaccine(RIBSP)
100 Deals associated with TB/FLU-01L Tuberculosis Vaccine(RIBSP)